Netra.ai – Fighting the dreaded ‘D’ (Diabetic Retinopathy) with AI

a1

a1

Living in a world of daily breakthroughs in almost every field of life gives everyone that sense of security and belief that most of the issues they encounter and have no knowledge of being bailed out are actually being worked out and have a solution ready for them. Technologists have been working round the clock to make life and its surprises easier for people by developing path breaking innovations only to benefit humanity and the world at large.

At Leben care we have put ourselves to service and innovate to counter the dreaded issue of blindness caused by diabetes which is also known as Diabetic Retinopathy. An incredible investment of time and expertise went in to develop an advanced Artificial Intelligence based platform for early detection of Diabetic Retinopathy called Netra.ai. Now Diabetic Retinopathy is something which goes undetected and mostly symptomless which may start as early as just turning an adult. Early detection and diagnosis of Diabetic Retinopathy sure prevents vision loss and is incredibly beneficial to the patient.

In April 2018 FDA gave its first approval to its first AI Algorithm for the detection of Diabetic Retinopathy in the offices of non-medico health care centers. The images captured with the help of a Fundus camera are sent to a cloud-based server that utilizes the software and a deep learning algorithm to detect retinal findings consistent with diabetic retinopathy.

Netra.AI uses cutting edge Algorithms with a 4 step Deep Convolution Neural Network (DCNN). Algorithm is developed in guidance with some of the leading experts in Retina globally. Netra.AI enables automated and point of care Retinal Image Analysis.

  1. Reduce incidence of blindness by timely identification of patients at risk
  2. Offer insights to medical practitioners thus enabling improved diagnostic outcome

 

What Netra.ai does is; analyze Fundus Camera images which are further integrated with a cloud based web portal for immediate test results of Diabetic Retinopathy, Diabetic Macular Edema, Glaucoma, AMD and a host of other retinal conditions. Netra.ai empowers both the Doctor and patient to keep a record and manage the changes in Retinal health over the time, Netra.ai tracks, maintains records of retinal images and automatically detects and highlights changes upon every follow-up visit, enabling better visualization and control over disease progression.

The benefits Netra.ai brings along are unmatched due to the greatly reduced time in diagnosis, the accuracy and efficiency of results acquired through it. Netra.ai holds an impeccable value for not just patients but to its mobility and minimal infra capability it is highly beneficial for:

  • Optometrists
  • Diagnostic Centers
  • Wellness Providers
  • GP’s, Clinicians, Diabetologists
  • Ophthalmologists, Retina Specialists
  • Governmental Organizations
  • Non-Governmental Organizations
  • Social Impact Organizations

Netra.ai has high sensitivity in detecting Retinal issues including Diabetic Retinopathy and Sight Threatening Diabetic Retinopathy. The automated analysis of retinal imaging using a Fundus Camera integrated with Artificial Intelligence is feasible and economical for mass screening of diabetic patients with a suspected case of retinal damage or a routine cycle check up to keep oneself updated about the status of their retinal health.

Out of 100 diabetics, about 20 will have some problem in eye, of which 5 would be referred to an eye doctor for urgent care and the remaining 15 would need close follow-up-Dr R. Kim, CMO, Aravind Eye Hospitals

Log in with your credentials

Forgot your details?